Cyclerion Therapeutics, Inc.

Contributing Author

Recent Articles by Cyclerion Therapeutics, Inc.

Jan-05	Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression CYCN +41.30% CYCN GlobeNewswire
Sep-23	Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company CYCN +7.62% CYCN GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information